CJC-1295
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone (GHRH), studied for its ability to increase endogenous growth hormone (GH) and IGF-1 secretion.
- This modification allows for sustained elevation of endogenous GH and IGF-1 levels for up to a week following administration.
- Research has focused on CJC-1295’s potential to stimulate pulsatile growth hormone release, promoting anabolic processes such as protein synthesis, lipolysis, and tissue repair.
- It has also been studied in contexts related to muscle recovery, metabolic health, and age-related hormonal decline.
Product overview
CJC-1295 is a tetrasubstituted peptide designed to mimic the action of growth hormone-releasing hormone (GHRH) while offering enhanced stability and prolonged half-life through binding to albumin via a Drug Affinity Complex (DAC). This modification allows for sustained elevation of endogenous GH and IGF-1 levels for up to a week following administration. Research has focused on CJC-1295’s potential to stimulate pulsatile growth hormone release, promoting anabolic processes such as protein synthesis, lipolysis, and tissue repair. It has also been studied in contexts related to muscle recovery, metabolic health, and age-related hormonal decline. Unlike exogenous growth hormone administration, CJC-1295 supports the natural feedback-regulated GH axis, potentially reducing the risk of hormonal suppression. Its long-acting profile and physiological mechanism make it a key candidate in experimental endocrinology, regenerative medicine, and aging-related research.
Studied in research on receptor-specific peptide signaling and endocrine pathways.
Every batch is independently tested at two accredited third-party laboratories. Each shipment is accompanied by a batch-specific Certificate of Analysis. Material Safety Data Sheets (MSDS) and Laboratory Chemical Safety Summaries (LCSS) are available on request.
Research use
Studied in research on receptor-specific peptide signaling and endocrine pathways.
Storage
Store lyophilized at 2–8 °C; refrigerate after reconstitution.
Presentation
Lyophilized peptide in a sealed vial. Reconstitute with bacteriostatic water.
Quality assurance
Independently verified at two accredited third-party laboratories. Batch-specific COA included with every shipment.
Research use only. All EBIOM products are supplied strictly for laboratory and preclinical research. They are not intended for human or veterinary use, diagnosis, or treatment of any medical condition. Handling must comply with all applicable laws and institutional safety guidelines.
